<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">JCNR</journal-id><journal-title-group><journal-title>Journal of Clinical and Nursing Research</journal-title></journal-title-group><issn>2208-3685</issn><eissn>2208-3693</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/jcnr.v9i4.10405</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Progress in Interventional and Surgical Treatment of Obstructive Hypertrophic Cardiomyopathy </title><url>https://artdesignp.com/journal/JCNR/9/4/10.26689/jcnr.v9i4.10405</url><author>QiaoYoujin</author><pub-date pub-type="publication-year"><year>2025</year></pub-date><volume>9</volume><issue>4</issue><history><date date-type="pub"><published-time>2025-04-29</published-time></date></history><abstract>To improve the treatment effect of obstructive hypertrophic cardiomyopathy, this article focuses on the treatment of obstructive hypertrophic cardiomyopathy and conducts a comprehensive analysis of the disease. It highlights the limitations of traditional treatment methods and elaborates on interventional and surgical treatments. Additionally, this article compares the indications, risks, treatment effects, and costs of the two different treatment methods, providing a reference for doctors and patients in selecting clinical treatment plans.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Wen Y, Yang M, Hu H, 2022, Progress in the Treatment of Obstructive Hypertrophic Cardiomyopathy to Relieve Obstruction. Advances in Cardiovascular Diseases, 43(9): 799–802, 811.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Liu S, Ma Z, Shao H, et al., 2024, Changes in Electrocardiogram After Percutaneous Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy. Chinese Journal of Cardiac Pacing and Electrophysiology, 38(2): 100–104.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Yao S, Luo S, Huang B, 2024, Research Status of Myocardial Myosin Inhibitors in the Treatment of Obstructive Hypertrophic Cardiomyopathy. Advances in Cardiovascular Diseases, 45(5): 397–401.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Wei P, Feng S, Fang F, et al., 2024, Transcatheter Mitral Valve Edge-to-Edge Repair for Non-Obstructive Hypertrophic Cardiomyopathy With Severe Mitral Regurgitation: A Case Report. Chinese Journal of Cardiology, 52(5): 534–537.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Sun J, Li P, Yu X, et al., 2023, Comparative Study on the Prognosis of Septal Ablation in the Treatment of Patients With Mild and Severe Obstructive Hypertrophic Cardiomyopathy. Chinese Journal of Cardiology, 51(5): 513–520.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Liu F, Ji Q, Wang Y, et al., 2023, Surgical Treatment of Obstructive Hypertrophic Cardiomyopathy: A 5-Year Experience of 421 Cases in a Single Center. Chinese Journal of Surgery, 61(3): 201–208.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Liang S, Pu Z, 2023, Technical Essentials and Research Progress in the Treatment of Obstructive Hypertrophic Cardiomyopathy. Journal of Electrocardiology and Circulation, 42(4): 315–319.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Chen Y, Liu H, Chen H, et al., 2022, Systematic Evaluation and Meta-Analysis of the Efficacy and Safety of Radiofrequency Ablation in the Treatment of Obstructive Hypertrophic Cardiomyopathy. Chinese Journal of Interventional Cardiology, 30(12): 940–949.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Lei C, Wang J, Liu L, 2024, New Progress in the Treatment of Obstructive Hypertrophic Cardiomyopathy With Liwen Procedure. Advances in Cardiovascular Diseases, 45(11): 964–967.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Guo H, Wei P, 2023, Challenges and Future of Surgical Treatment for Obstructive Hypertrophic Cardiomyopathy. Chinese Journal of Surgery, 61(3): 181–186.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
